Popular US stocks traded on POEMS in February 2022 March 10, 2022

Popular US stocks traded on POEMS in February 2022

Here are some of the most popular US stocks – not in any order of ranking – traded by POEMS customers in February.

News headlines in February at a glance

  • Russia invades Ukraine leading to a market selloff
  • Gold reaches 15-month high
  • 5.7% annualised GDP growth is the fastest since 1984

The three US major indices – Dow Jones, S&P 500 and Nasdaq Composite – dropped and fell into correction territory.

Month Open 14,277.43 35,151.47 4519.57
Month Close 13,751.40 33,892.61 4,373.95
Monthly return -3.68% -3.58% -3.22%

Events in February were overshadowed by the conflict between Russia and Ukraine. After months of tension between the two countries, Russia’s President Vladimir Putin ordered the invasion of Ukraine on 23 February 20221. There was a market-wide selloff on the day of the invasion, with technology stocks leading the selloff2. Gold, considered a safe haven reached a 15-month high due to the conflict3. There will be more updates on our POEMS app.

The fourth quarter GDP of the United States increased at a 7% annualized rate, taking the annualised GDP growth rate to 5.7%4. The 5.7% growth rate is the fastest since 1984 and was mainly due to inventory rebuilding to minimise the supply chain impact. In January, retail sales surged while in February, business activity rebounded5. Increase in spending creates an upside risk for the first quarter’s GDP growth.

Amazon Inc (NASDAQ:AMZN)

AMZN opened February at US$3,000 and gain 2.8%% to close at US$3,071.26 despite poor guidance. AMZN guided first quarter revenue of between US$112 billion and US$117 billion, below the average estimate of US$120 billion. However, AMZN’s reported earnings per share (EPS) of US$5.80 beat estimates of US$3.57, while revenue was reported at US$137.4 billion, slightly missing estimates of US$137.6. AMZN also reported their Amazon Web Service (AWS) revenue climbed almost 40% to US$17.78 billion, beating estimates of US$17.37. AMZN was able to give investors’ confidence that growth will recover, which could be the reason for AMZN’s gains this month.6

Based on Phillip Securities Research (PSR), AMZN is a BUY with a target price of US$ 4079.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 2984.76
Immediate Resistance: 3195.94

CVS Health Corporation (NYSE:CVS)

CVS’s earnings beat estimates for the 2021 fourth quarter7. CVS opened this month at US$106.27 and dropped 2.5% to close at US$103.65. EPS of US$1.98 and revenue of US$76.60 billion both beat estimates of US$1.93 and US$75.67 billion respectively. This pandemic helped CVS’s retail and pharmacy businesses, especially during the holiday season when booster shots and test kits were more sought after. The management team is venturing into other areas of healthcare and leveraging on its scale to reduce costs and provide better outcomes.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 104.21
Immediate Resistance: 106.19

Walt Disney Company (NYSE: DIS)

DIS opened February at US$143.02 and gained 10.1% to close at US$157.50. The reported earnings per share (EPS) of US$1.06 and revenue of US$21.83 billion beat estimates of US$0.63 and US$20.91 billion respectively. Disney+ subscriptions of 129.8 million also beat estimates of 125.75 million. DIS expects significant progress by fiscal 2023, and reiterated guidance for Disney+ subscribers of 230 million to 260 million by 2024.8

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 145.07
Immediate Resistance: 160.21

Roblox Corporation (NYSE:RBLX)

RBLX missed earnings for the fourth quarter of 20219. RBLX loss per share for the quarter was US$0.25 which is around 92% worse than the expected loss per share of -US$ 0.13. Revenue of US$770 million too was worse than the expected revenue of US$772 million. However, their daily active users of 49.5 million is up 33% year-on-year. RBLX started February at US$66.31 and closed 22.2% lower at US$51.57.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Bearish
Immediate Support: 42
Immediate Resistance: 50.52
Bearish momentum unless price can hold above 50.5 for more potential upside

Qualcomm Incorporated (NASDAQ: QCOM)

QCOM delivered earnings results that beat estimates this quarter. QCOM earnings per share (EPS) was reported at US$3.23 against the estimate of US$3.01. Reported revenue was higher than the estimate of US$10.7 billion against the expected US$10.42 billion. QCOM expects between $10.2 billion and $11 billion in sales in the upcoming quarter, ahead of analyst estimates of $9.6 billion10. QCOM started February at US$176.44 and closed at US$171.99 which is 2.5% lower.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 161.41
Immediate Resistance: 173.18

Meta Platforms Inc (NASDAQ:FB)

FB dropped 32.9% in February. It opened at US$314.56 and closed at US$211.03. This drop in price was likely due to FB’s disappointing earnings being reported and weak guidance given, saying that user growth has stagnated. Earnings per share (EPS) were reported at US$3.67, missing estimates of US$3.84 while revenue was reported at US$33.67 billion, slightly better than estimates of US$33.4 billion11.

Based on Phillip Securities Research (PSR), FB is a BUY with a target price of US$312.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Bearish
Immediate Support: 202.11
Immediate Resistance: 217.35

Advanced Micro Devices (NASDAQ: AMD)

AMD beat earnings estimates for this quarter. AMD’s EPS of US$0.92 and revenue of US$4.83 billion are higher than the estimates of US$0.76 and US$4.53 billion respectively. AMD expects a strong sales outlook of US$21.5 billion, ahead of analyst expectations of US$19.26 billion, a 31% increase from 2021 sales. AMD also expects $5 billion in sales in the first quarter, driven by server and PC processor sales. AMD opened February at US$116.75 and gained 5.64% to close at US$123.34.12

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 112.72
Immediate Resistance: 128.58

Foot Locker Inc (NYSE:FL)

FL beat the second quarter’s estimate and its management deems the second half of the year favourable13. FL EPS for the second quarter was US$2.21 which is around 119% higher than the expected EPS of US$1.01. Revenue increased 9.5%, from US$ 2.08 billion to US$ 2.28 billion, beating the expected revenue of US$2.09 billion. Despite the COVID-19 pandemic, consumers are still spending on athletic footwear and workout apparel which was partly why FL was able to beat estimates. FL started February at US$ 44.73 and closed 28.8% lower at US$ 31.62.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 26.64
Immediate Resistance: 31.16

Airbnb Inc (NASDAQ:ABNB)

ABNB delivered great results last quarter with strong guidance14 . ABNB EPS for the fourth quarter was US$0.08 which is around 166% higher than the expected EPS of US$0.03. Revenue of US$1.53 billion too, beat the expected revenue of US$1.46 billion. However, the 73.4 million nights and experiences booked were 8% lower than the previous quarter and missed estimates. The management expects the following quarter’s nights and experiences booked to be way higher than Q1 2019 levels. ABNB started February at US$155.35 and closed 2.48% lower at US$151.49.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 138.01
Immediate Resistance: 158.99

Under Armour (NYSE:UA)

UA shares fell despite earnings beating estimates15. UA opened February at US$16.12 and lost 3.04% to close at US$15.63. UA’s EPS of US$ 0.14 and revenue of US$ 1.53 billion both beat estimates of US$0.07 and US$1.47 billion respectively. UA’s apparel sales grew 18% and footwear was up 17%, accessories, however, fell by 27%. The management team is trying to brand Under Armour as a premium label which will be on par with brands like Nike. As for the coming quarter, UA believes that supply chain constraints will put pressure on sales.

Popular US stocks traded on POEMS in February 2022

Technical Analysis: Neutral
Immediate Support: 14.27
Immediate Resistance: 15.71

Bloomberg analysts’ recommendations

The table below shows the consensus ratings and average ratings of all analysts updated on Bloomberg in the last 12 months. Consensus ratings have been computed by standardising analysts’ ratings from a scale of 1 (Strong Sell) to 5 (Strong Buy). The table also shows a number of analysts’ recommendations to buy, hold or sell the stocks, as well as their average target prices.

Security Consensus Rating BUY HOLD SELL 12 Mth Target Price (US$)
Amazon Inc (NASDAQ:AMZN) 4.96 57 (100%) 0 0 4130.54
CVS Health Corporation (NYSE:CVS) 4.52 22 (75.9%) 7 (24.1%) 0 117.84
Walt Disney Company (NYSE: DIS) 4.49 26 (74.3%) 9 (25.7%) 0 192.31
Roblox Corporation (NYSE:RBLX) 4.45 16 (80%) 3 (15%) 1 (5%) 82.97
Qualcomm Incorporated (NASDAQ: QCOM) 4.42 27 (71.1%) 11 (28.9%) 0 213.93
Meta Platforms Inc (NASDAQ:FB) 4.35 46 (74.2%) 13 (21%) 3 (4.8%) 332.26
Advanced Micro Devices (NASDAQ: AMD) 4.11 28 (60.9%) 16 (34.8%) 2 (4.3%) 151.16
Foot Locker Inc (NYSE:FL) 3.91 13 (59.1%) 6 (27.3%) 3 (13.6%) 58.25
Airbnb Inc (NASDAQ:ABNB) 3.59 16 (41%) 20 (51.3%) 3 (7.7%) 200.52
Under Armour (NYSE:UA)

To round up

With the ongoing geopolitical tension, it seems that volatility will continue for a while. As for March, the Federal Reserve Open Market Committee is scheduled to meet on March 16-17. The market is highly certain that interest rates will be raised. The uncertainty lies in the number and timing of the rate hikes.

Want to get daily updates on market events? You can join our Telegram Channel here.

Popular US stocks traded on POEMS in February 2022

Trade Smarter and Faster
With our newly launched POEMS Mobile 3 Trading App

Explore a myriad of useful features including Trading View chartings to conduct technical analysis, stock analytics from our in-house research analysts, and more available for you anytime and anywhere to elevate you as a better trader.



These commentaries are intended for general circulation. It does not have regard to the specific investment objectives, financial situation and particular needs of any person who may receive this document. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of any person acting based on this information. Opinions expressed in these commentaries are subject to change without notice. Investments are subject to investment risks including the possible loss of the principal amount invested. The value of the units and the income from them may fall as well as rise. Past performance figures as well as any projection or forecast used in these commentaries are not necessarily indicative of future or likely performance. Phillip Securities Pte Ltd (PSPL), its directors, connected persons or employees may from time to time have an interest in the financial instruments mentioned in these commentaries. Investors may wish to seek advice from a financial adviser before investing. In the event that investors choose not to seek advice from a financial adviser, they should consider whether the investment is suitable for them.

The information contained in these commentaries has been obtained from public sources which PSPL has no reason to believe are unreliable and any analysis, forecasts, projections, expectations and opinions (collectively the “Research”) contained in these commentaries are based on such information and are expressions of belief only. PSPL has not verified this information and no representation or warranty, express or implied, is made that such information or Research is accurate, complete or verified or should be relied upon as such. Any such information or Research contained in these commentaries are subject to change, and PSPL shall not have any responsibility to maintain the information or Research made available or to supply any corrections, updates or releases in connection therewith. In no event will PSPL be liable for any special, indirect, incidental or consequential damages which may be incurred from the use of the information or Research made available, even if it has been advised of the possibility of such damages. The companies and their employees mentioned in these commentaries cannot be held liable for any errors, inaccuracies and/or omissions howsoever caused. Any opinion or advice herein is made on a general basis and is subject to change without notice. The information provided in these commentaries may contain optimistic statements regarding future events or future financial performance of countries, markets or companies. You must make your own financial assessment of the relevance, accuracy and adequacy of the information provided in these commentaries.

Views and any strategies described in these commentaries may not be suitable for all investors. Opinions expressed herein may differ from the opinions expressed by other units of PSPL or its connected persons and associates. Any reference to or discussion of investment products or commodities in these commentaries is purely for illustrative purposes only and must not be construed as a recommendation, an offer or solicitation for the subscription, purchase or sale of the investment products or commodities mentioned.

About the author

Jonah Sim Hong Chee (Dealer), Lee Ying Jie (Dealer) & Chan Zi Quan (Dealer)

Jonah Sim is a US Equity Dealer in the Global Markets Team and specializing in US and Canadian markets. He graduated from University of Essex with a bachelor’s degree in Banking and Finance.

Ying Jie is a US Equity Dealer in the Global Markets Team and specializing in US and Canadian markets. He is proficient in trading using Technical Analysis, placing emphasis on supply and demand, and price action.

Zi Quan is a US Equity Dealer in the Global Markets Team and specializes in the US and Canadian markets. He is an avid crypto fan and is adept in macro analysis..

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you


This material is provided by Phillip Capital Management (S) Ltd (“PCM”) for general information only and does not constitute a recommendation, an offer to sell, or a solicitation of any offer to invest in any of the exchange-traded fund (“ETF”) or the unit trust (“Products”) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. You should read the Prospectus and the accompanying Product Highlights Sheet (“PHS”) for key features, key risks and other important information of the Products and obtain advice from a financial adviser (“FA“) pursuant to a separate engagement before making a commitment to invest in the Products. In the event that you choose not to obtain advice from a FA, you should assess whether the Products are suitable for you before proceeding to invest. A copy of the Prospectus and PHS are available from PCM, any of its Participating Dealers (“PDs“) for the ETF, or any of its authorised distributors for the unit trust managed by PCM.  

An ETF is not like a typical unit trust as the units of the ETF (the “Units“) are to be listed and traded like any share on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Listing on the SGX-ST does not guarantee a liquid market for the Units which may be traded at prices above or below its NAV or may be suspended or delisted. Investors may buy or sell the Units on SGX-ST when it is listed. Investors cannot create or redeem Units directly with PCM and have no rights to request PCM to redeem or purchase their Units. Creation and redemption of Units are through PDs if investors are clients of the PDs, who have no obligation to agree to create or redeem Units on behalf of any investor and may impose terms and conditions in connection with such creation or redemption orders. Please refer to the Prospectus of the ETF for more details.  

Investments are subject to investment risks including the possible loss of the principal amount invested. The purchase of a unit in a fund is not the same as placing your money on deposit with a bank or deposit-taking company. There is no guarantee as to the amount of capital invested or return received. The value of the units and the income accruing to the units may fall or rise. Past performance is not necessarily indicative of the future or likely performance of the Products. There can be no assurance that investment objectives will be achieved.  

Where applicable, fund(s) may invest in financial derivatives and/or participate in securities lending and repurchase transactions for the purpose of hedging and/or efficient portfolio management, subject to the relevant regulatory requirements. PCM reserves the discretion to determine if currency exposure should be hedged actively, passively or not at all, in the best interest of the Products.  

The regular dividend distributions, out of either income and/or capital, are not guaranteed and subject to PCM’s discretion. Past payout yields and payments do not represent future payout yields and payments. Such dividend distributions will reduce the available capital for reinvestment and may result in an immediate decrease in the net asset value (“NAV”) of the Products. Please refer to <www.phillipfunds.com> for more information in relation to the dividend distributions.  

The information provided herein may be obtained or compiled from public and/or third party sources that PCM has no reason to believe are unreliable. Any opinion or view herein is an expression of belief of the individual author or the indicated source (as applicable) only. PCM makes no representation or warranty that such information is accurate, complete, verified or should be relied upon as such. The information does not constitute, and should not be used as a substitute for tax, legal or investment advice.  

The information herein are not for any person in any jurisdiction or country where such distribution or availability for use would contravene any applicable law or regulation or would subject PCM to any registration or licensing requirement in such jurisdiction or country. The Products is not offered to U.S. Persons. PhillipCapital Group of Companies, including PCM, their affiliates and/or their officers, directors and/or employees may own or have positions in the Products. Any member of the PhillipCapital Group of Companies may have acted upon or used the information, analyses and opinions herein before they have been published. 

This advertisement has not been reviewed by the Monetary Authority of Singapore.  


Phillip Capital Management (S) Ltd (Co. Reg. No. 199905233W)  
250 North Bridge Road #06-00, Raffles City Tower ,Singapore 179101 
Tel: (65) 6230 8133 Fax: (65) 65383066 www.phillipfunds.com